Biora Therapeutics, Inc. (NASDAQ:BIOR – Get Free Report)’s stock price traded up 6.5% during trading on Monday . The company traded as high as $0.16 and last traded at $0.15. 16,292 shares changed hands during trading, a decline of 78% from the average session volume of 74,868 shares. The stock had previously closed at $0.14.
Biora Therapeutics Stock Up 6.5%
The company’s 50 day simple moving average is $0.14 and its two-hundred day simple moving average is $0.24. The company has a market capitalization of $659,905.70, a price-to-earnings ratio of -0.01 and a beta of 1.12.
About Biora Therapeutics
Biora Therapeutics, Inc, a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases.
See Also
- Five stocks we like better than Biora Therapeutics
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- New Catalysts to Drive NVIDIA’s Stock Price Even Higher
- What is a Special Dividend?
- China Market Movers: MCHI, PDD, BIDU Show Bullish Trends
- Market Cap Calculator: How to Calculate Market Cap
- Palantir Defies Bears, Leads S&P 500 in 2025
Receive News & Ratings for Biora Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biora Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
